153 related articles for article (PubMed ID: 11017118)
21. FDA notifications. FDA approves label change for nevirapine.
AIDS Alert; 2008 Aug; 23(8):91-2. PubMed ID: 18724490
[No Abstract] [Full Text] [Related]
22. The domestic drug regulatory process: why time is of the essence.
Katz R
Epilepsy Res Suppl; 1993; 10():91-106. PubMed ID: 8251109
[No Abstract] [Full Text] [Related]
23. Generic stavudine approved.
AIDS Patient Care STDS; 2009 May; 23(5):396-7. PubMed ID: 19422067
[No Abstract] [Full Text] [Related]
24. Mandatory comparator trials for therapeutically similar drugs: an assessment of the facts.
Milne CP; Kaitin KI; Dimasi JA
Am J Ther; 2007; 14(3):231-4. PubMed ID: 17515695
[No Abstract] [Full Text] [Related]
25. Pediatric regulatory initiatives.
Hirschfeld S; Saint-Raymond A
Handb Exp Pharmacol; 2011; 205():245-68. PubMed ID: 21882115
[TBL] [Abstract][Full Text] [Related]
26. New clinical trials policy at FDA.
Vastag B
Nat Biotechnol; 2006 Sep; 24(9):1043. PubMed ID: 16964196
[No Abstract] [Full Text] [Related]
27. [The pediatric drug initiative].
Krankenpfl J; 2005; 43(7-10):218-9. PubMed ID: 16515290
[No Abstract] [Full Text] [Related]
28. The Pediatric Research Equity Act Moves Into Adolescence.
Bourgeois FT; Hwang TJ
JAMA; 2017 Jan; 317(3):259-260. PubMed ID: 28114560
[No Abstract] [Full Text] [Related]
29. The Best Pharmaceuticals for Children Act of 2002: the rise of the voluntary incentive structure and congressional refusal to require pediatric testing.
Breslow LH
Harvard J Legis; 2003; 40(1):133-93. PubMed ID: 16594116
[TBL] [Abstract][Full Text] [Related]
30. FDA notifications. FDA approves pediatric dosing for ritonavir.
AIDS Alert; 2005 Nov; 20(11):129-30. PubMed ID: 16365934
[No Abstract] [Full Text] [Related]
31. Drive for drugs leads to baby clinical trials.
Nature; 2006 Mar; 440(7083):406-7. PubMed ID: 16554774
[No Abstract] [Full Text] [Related]
32. Cancer drug approval in the United States, Europe, and Japan.
Milsted RA
Adv Cancer Res; 2007; 96():371-91. PubMed ID: 17161686
[No Abstract] [Full Text] [Related]
33. Pediatric clinical trials: shall we take a lead?
Schreiner MS; Greeley WJ
Anesth Analg; 2002 Jan; 94(1):1-3. PubMed ID: 11772791
[No Abstract] [Full Text] [Related]
34. Stimulation programs for pediatric drug research--do children really benefit?
Boots I; Sukhai RN; Klein RH; Holl RA; Wit JM; Cohen AF; Burggraaf J
Eur J Pediatr; 2007 Aug; 166(8):849-55. PubMed ID: 17225950
[TBL] [Abstract][Full Text] [Related]
35. To market, to market. The nuts and bolts of prescription drug approval.
Peterson AM
Adv Nurse Pract; 2001 Apr; 9(4):87-90. PubMed ID: 12420443
[No Abstract] [Full Text] [Related]
36. Impact of new regulations for pediatric labeling by the Food and Drug Administration.
Buck ML
Pediatr Nurs; 2000; 26(1):95-6. PubMed ID: 12026326
[No Abstract] [Full Text] [Related]
37. Pediatric clinical trial experience: government, child, parent and physician's perspective.
Salazar JC
Pediatr Infect Dis J; 2003 Dec; 22(12):1124-7. PubMed ID: 14688585
[TBL] [Abstract][Full Text] [Related]
38. On approval.
Huff B
GMHC Treat Issues; 2001 Oct; 15(10):5-8. PubMed ID: 11727570
[No Abstract] [Full Text] [Related]
39. Proposed regulations would mandate pediatric testing for many drugs.
Am J Health Syst Pharm; 1997 Oct; 54(19):2152. PubMed ID: 9331433
[No Abstract] [Full Text] [Related]
40. Pediatric drug development in anesthesiology: an FDA perspective.
Schultheis LW; Mathis LL; Roca RA; Simone AF; Hertz SH; Rappaport BA
Anesth Analg; 2006 Jul; 103(1):49-51. PubMed ID: 16790624
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
